Design Therapeutics, Inc. (DSGN)
DSGN Stock Price Chart
Explore Design Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze DSGN price movements and trends.
DSGN Company Profile
Discover essential business fundamentals and corporate details for Design Therapeutics, Inc. (DSGN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
29 Mar 2021
Employees
56.00
Website
https://www.designtx.comCEO
Pratik Shah
Description
Design Therapeutics, Inc. is a biopharmaceutical company in the preclinical phase that focuses on creating treatments for genetic conditions stemming from nucleotide repeat expansions. Its current pipeline targets Friedreich's Ataxia (FA), a severe, progressive, monogenic, and autosomal recessive disease. FA primarily impairs mitochondrial function across various organ systems, resulting in neurological, cardiac, and metabolic complications. Another significant area of development is Myotonic Dystrophy Type-1 (DM1). This is a progressive, dominantly inherited monogenic neuromuscular illness that impacts skeletal muscle, the heart, brain, and other bodily systems. Beyond these, the company is advancing its GeneTAC product candidate platform to address an array of other monogenic conditions caused by nucleotide repeat expansions. These include Fragile X syndrome, various spinocerebellar ataxias, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, Huntington's disease, and spinobulbar muscular atrophy. Established in 2017, Design Therapeutics, Inc. maintains its headquarters in Carlsbad, California.
DSGN Financial Timeline
Browse a chronological timeline of Design Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.36.
Earnings released on 28 Apr 2026
EPS came in at -$0.29 surpassing the estimated -$0.36 by +19.44%.
Earnings released on 9 Mar 2026
EPS came in at -$0.27 surpassing the estimated -$0.38 by +28.95%.
Earnings released on 5 Nov 2025
EPS came in at -$0.30 surpassing the estimated -$0.34 by +11.76%.
Earnings released on 7 Aug 2025
EPS came in at -$0.34 falling short of the estimated -$0.32 by -6.25%.
Earnings released on 7 May 2025
EPS came in at -$0.31 falling short of the estimated -$0.28 by -10.71%.
Earnings released on 10 Mar 2025
EPS came in at -$0.24 surpassing the estimated -$0.28 by +14.29%.
Earnings released on 7 Nov 2024
EPS came in at -$0.23 surpassing the estimated -$0.26 by +11.54%.
Earnings released on 5 Aug 2024
EPS came in at -$0.21 surpassing the estimated -$0.25 by +16.00%.
Earnings released on 8 May 2024
EPS came in at -$0.20 surpassing the estimated -$0.28 by +28.57%.
Earnings released on 19 Mar 2024
EPS came in at -$0.21 surpassing the estimated -$0.32 by +34.38%, while revenue for the quarter reached $838.00k .
Earnings released on 13 Nov 2023
EPS came in at -$0.28 surpassing the estimated -$0.42 by +33.33%.
Earnings released on 14 Aug 2023
EPS came in at -$0.36 surpassing the estimated -$0.41 by +12.20%.
Earnings released on 9 May 2023
EPS came in at -$0.35 surpassing the estimated -$0.37 by +5.41%.
Earnings released on 14 Mar 2023
EPS came in at -$0.31 surpassing the estimated -$0.34 by +8.82%.
Earnings released on 3 Nov 2022
EPS came in at -$0.32 falling short of the estimated -$0.28 by -14.29%.
Earnings released on 8 Aug 2022
EPS came in at -$0.27 falling short of the estimated -$0.25 by -8.00%.
Earnings released on 9 May 2022
EPS came in at -$0.24 falling short of the estimated -$0.22 by -9.09%.
Earnings released on 10 Mar 2022
EPS came in at -$0.20 surpassing the estimated -$0.22 by +9.09%.
Earnings released on 9 Nov 2021
EPS came in at -$0.21 falling short of the estimated -$0.14 by -50.00%.
Earnings released on 9 Aug 2021
EPS came in at -$0.14 surpassing the estimated -$0.18 by +22.22%.
DSGN Stock Performance
Access detailed DSGN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
